Semaglutide 6-months therapy of type 2 diabetes mellitus restores adipose progenitors potential to develop metabolically active adipocytes
Iurii Stafeev, Margarita Agareva, Svetlana Michurina, A. Tomilova, Ekaterina А. Shestakova, Ekaterina Zubkova, M. S. Sineokaya, Е. И. Ратнер, Mikhail Menshikov, Yelena Parfyonova, Marina V. Shestakova
Topics & Concepts
SemaglutideInternal medicineEndocrinologyAdipose tissueAdipogenesisWhite adipose tissueMedicineProgenitor cellType 2 diabetesBiologyDiabetes mellitusStem cellCell biologyLiraglutideDiabetes Treatment and ManagementAdipose Tissue and MetabolismMetabolism, Diabetes, and Cancer